Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2019 first-quarter earnings
FINAL LEDE- What You Need to Know About Johnson & Johnson's 2019 First-Quarter Earnings- Q1 Earnings 2019

What you need to know about Johnson & Johnson’s 2019 first-quarter earnings

Check out this infographic breakdown of the company’s first-quarter 2019 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon

Johnson & Johnson shared financial information this morning about its first-quarter performance in 2019.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“The strength of our first-quarter results reinforces the confidence we have in our outlook for 2019,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Utilizing the collective and individual skills of our 135,000 global Johnson & Johnson colleagues, we continue to optimize our portfolio with discipline and make investments across the enterprise that position us to continue achieving long-term, sustainable growth and deliver significant value to patients, healthcare providers and shareholders.”

For more details about the company’s first-quarter 2019 results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.


1q2019-jj-earnings-infographic-final-4-16.png

Johnson & Johnson’s 2019 1st-Quarter Earnings

Read the earnings press release, which includes full financial data for the first quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.